Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2
Because of its unique ability to exert long-lasting synaptic transmission blockade, botulinum neurotoxin A (BoNT/A) is used to treat a wide variety of disorders involving peripheral nerve terminal hyperexcitability. However, it has been a matter of debate whether this toxin has central or peripheral...
Main Authors: | Hidetaka eKoizumi, Satoshi eGoto, Shinya eOkita, Ryoma eMorigaki, Norio eAkaike, Yasushi eTorii, Tetsuhiro eHarakawa, Akihiro eGinnaga, Ryuji eKaji |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00098/full |
Similar Items
-
Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains
by: Satoshi eGoto, et al.
Published: (2015-03-01) -
Online training program maintains motor functions and quality of life in patients with Parkinson's disease
by: Hiroshi Nakanishi, et al.
Published: (2024-11-01) -
Dystonia: Still a Mysterious Syndrome
by: Ryoma Morigaki, et al.
Published: (2022-07-01) -
A methodology for fast assessments to the electrical activity of barrel fields in vivo: from population inputs to single unit outputs
by: Jorge J Riera, et al.
Published: (2014-02-01) -
Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
by: Stefan Sikorra, et al.
Published: (2020-12-01)